These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 14020632)

  • 21. Hydergine and vincamine derivative LD 4298 exhibit no anti-sickling properties in vitro.
    Roth E; Elbaum D; Godoy E; Nagel RL
    Nouv Rev Fr Hematol (1978); 1979 Jan; 20(4):611-9. PubMed ID: 440964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood-oxygen affinity and sickling in sickle cell disease: effect of prior deoxygenation.
    Sinet M; Pocidalo JJ
    J Lab Clin Med; 1981 Oct; 98(4):492-9. PubMed ID: 6793678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatal intravascular sickling in a patient with sickle-cell trait.
    OBER WB; BRUNO MS; WEINBERG SB; JONES FM; WEINER L
    N Engl J Med; 1960 Nov; 263():947-9. PubMed ID: 13730144
    [No Abstract]   [Full Text] [Related]  

  • 24. Hydergine and vincamine derivative LD 4298 exhibit no anti-sickling properties in vitro.
    Roth E; Elbaum D; Godoy E; Nagel RL
    Nouv Rev Fr Hematol (1978); 1978; 20(4):611-9. PubMed ID: 752153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. OBSERVATIONS ON THE SICKLING PHENOMENON.
    THOMPSON RB; HOLLOWAY CH
    Am J Med Technol; 1963; 29():379-84. PubMed ID: 14072387
    [No Abstract]   [Full Text] [Related]  

  • 26. Coping with sickle cell anemia in Nigerian universities: the case of Obafemi Awolowo University, Ile-Ife, Nigeria.
    Okumdi MC; Victor AO
    Soc Work Health Care; 2013; 52(6):578-98. PubMed ID: 23865973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Frequency of sickle-cell anemia in the population of "Cuatro Bocas," Parroquia Ricaurte, Mara municipality, Zulia state, Venezuela].
    Torres-Guerra E; Torres-Guerra T; Valbuena G; Arteaga Vizcaíno M; Soto L
    Invest Clin; 1993; 34(2):99-105. PubMed ID: 8123712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. L-arginine, the sickling phenomenon, and cystic fibrosis.
    Solomons C; Hathaway W; Cotton E
    Pediatrics; 1972 Jun; 49(6):933. PubMed ID: 5041331
    [No Abstract]   [Full Text] [Related]  

  • 29. Preliminary report on G6PD and sickling test in a malarial area: a concurrent study to malarial nephropathy.
    Otieno LS; Okelo GB; Kinuthia DM; Ondijo SO
    East Afr Med J; 1983 May; 60(5):310-3. PubMed ID: 6667640
    [No Abstract]   [Full Text] [Related]  

  • 30. The sickling process in relation to clinical manifestations.
    Bellingham AJ
    J Clin Pathol Suppl (R Coll Pathol); 1974; 8():23-5. PubMed ID: 4536364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mononeuropathy in sickle cell anemia: anatomical and pathophysiological basis for its rarity.
    Shields RW; Harris JW; Clark M
    Muscle Nerve; 1991 Apr; 14(4):370-4. PubMed ID: 1851248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies in sickle cell disease. I. Quantitative aspects of sickling in the newborn period.
    SHIELDS GS; LICHTMAN HC; MESSITE J; WATSON RJ
    Pediatrics; 1958 Aug; 22(2):309-18. PubMed ID: 13578517
    [No Abstract]   [Full Text] [Related]  

  • 33. [Sickle cell anemia and the affinity of the blood for oxygen].
    Pocidalo JJ; Sinet M
    C R Seances Soc Biol Fil; 1979; 173(2):303-13. PubMed ID: 159755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sickle cell trait and aviation.
    Long ID
    Aviat Space Environ Med; 1982 Oct; 53(10):1021-9. PubMed ID: 6184047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival rates and properties of sickle cell anemia red cells treated with nitrogen mustard.
    Roth EF; Wenz B; Lee HB; Fabry M; Chang H; Kaul DK; Baez S; Nagel RL
    Prog Clin Biol Res; 1987; 240():245-61. PubMed ID: 3615491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sickling phenomenon in the erythrocytes of wapiti (Cervus canadensis).
    Weber YB; Giacometti L
    J Mammal; 1972 Nov; 53(4):917-9. PubMed ID: 4654245
    [No Abstract]   [Full Text] [Related]  

  • 37. Sickling in vitro of reticulocytes from patients with sickle cell disease at venous oxygen tension.
    Horiuchi K; Onyike AE; Osterhout ML
    Exp Hematol; 1996 Jan; 24(1):68-76. PubMed ID: 8536795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbamyl phosphate mediated inhibition of the sickling of erythrocytes in whole blood in vitro from sickle cell anemia patients.
    Kraus LM; Kraus AP
    J Lab Clin Med; 1971 Nov; 78(5):843-4. PubMed ID: 5128893
    [No Abstract]   [Full Text] [Related]  

  • 39. Angiographic media and the sickling phenomenon.
    Richards D; Nulsen FE
    Surg Forum; 1971; 22():403-4. PubMed ID: 5121421
    [No Abstract]   [Full Text] [Related]  

  • 40. Viscosity and filtrability measurements of sickle-cell suspensions in the development of anti-sickling drugs.
    Ohnishi ST
    Blood Cells; 1982; 8(1):79-87. PubMed ID: 7115980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.